Windlas Biotech Limited (NSE:WINDLAS)
India · Delayed Price · Currency is INR 1,002.95
+8.75 (0.88%)
Aug 29, 2025, 3:30 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 20.87 billion as of August 29, 2025. Its market cap has increased by 13.34% in one year.
Market Cap
20.87B
Enterprise Value
18.80B
Revenue
7.95B
Ranking
n/a
PE Ratio
32.46
Stock Price
1,002.95
Market Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 20.87B, an increase of 135.16%. That is a compound annual growth rate of 23.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 20.87B | -4.11% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | 8.87B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,825.74B |
| Divi's Laboratories | 1,627.72B |
| Cipla | 1,283.84B |
| Apollo Hospitals Enterprise | 1,094.20B |
| Mankind Pharma | 1,020.09B |
| Zydus Lifesciences | 987.17B |
| Fortis Healthcare | 688.14B |
| Alkem Laboratories | 634.11B |